Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.250
0.00 (0.00%)
At close: Mar 6, 2026
Nuo Therapeutics Revenue
Nuo Therapeutics had revenue of $1.03M in the quarter ending September 30, 2025, with 178.23% growth. This brings the company's revenue in the last twelve months to $2.61M, up 123.72% year-over-year. In the year 2024, Nuo Therapeutics had annual revenue of $1.37M with 124.34% growth.
Revenue (ttm)
2.61M
Revenue Growth
+123.72%
P/S Ratio
23.11
Revenue / Employee
290.17K
Employees
9
Market Cap
60.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 292.21M |
| Arch Biopartners | 115.29K |
| ZIVO Bioscience | 209.03K |
| Harvard Apparatus Regenerative Technology | 743.00K |
| Provectus Biopharmaceuticals | 350.44K |
| Vaxart | 148.20M |
Nuo Therapeutics News
- 11 months ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 11 months ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 2 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 2 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire